Side Effects of Combined Therapy of Methylprednisolone and Intravenous Immunoglobulin in Guillain-Barré Syndrome

Publisher： Karger

E-ISSN： 1421-9913|53|4|194-196

ISSN： 0014-3022

Source： European Neurology, Vol.53, Iss.4, 2005-07, pp. : 194-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 167-168

Karger

Access to resources Recommend Favorite

Improvement of Cytomegalovirus-Related Guillain-Barré Syndrome after High Doses of Intravenous Methylprednisolone Pulses

By  

European Neurology, Vol. 56, Iss. 1, 2006-09 ,pp. : 41-43

Karger

Access to resources Recommend Favorite

A Preliminary, Randomized, Multicenter Study Comparing Intravenous Immunoglobulin, Plasma Exchange, and Immune Adsorption in Guillain-Barré Syndrome

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 107-109

Karger

Access to resources Recommend Favorite

‘Hyperacute’ Guillain-Barré Syndrome

By  

European Neurology, Vol. 59, Iss. 1-2, 2007-10 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

The Epidemiology of Guillain-Barré Syndrome Worldwide

By  

Neuroepidemiology, Vol. 32, Iss. 2, 2008-12 ,pp. : 150-163

Karger

Access to resources Recommend Favorite